Dr. Nathan Pennell is a board-certified medical oncologist who specializes in the treatment of thoracic malignancies, with a focus on lung cancer. He joined the staff of the Taussig Cancer Center in 2008 and was appointed director of the TCI lung cancer medical oncology program in 2010. He holds a professorship at the Cleveland Clinic Lerner College of Medicine.

Dr. Pennell received his Ph.D. in neuroscience and M.D. from the University of Florida College of Medicine in Gainesville, FL. He completed his internal medicine residency at Brigham and Women's Hospital in Boston, MA, and his medical oncology fellowship at the Dana Farber Cancer Institute. His research interests include clinical trials using novel therapies with the goal of bringing new treatments from the lab to the clinic. He is a member of the American Society of Clinical Oncology and the International Association for the Study of Lung Cancer.